Insights

Market Leadership NIOX Group plc is recognized as the global leader in FeNO testing for asthma diagnosis and management, providing a strong presence in the respiratory diagnostics market that can be leveraged to expand sales and partnerships.

Healthcare Partnerships Recent collaborations with Vitalograph and AHSN Network highlight opportunities to deepen relationships with healthcare providers, clinics, and hospital networks seeking reliable asthma testing solutions.

Product Innovation The flagship NIOX VERO® device offers a non-invasive, easy-to-use testing method, appealing to healthcare professionals aiming for efficient and accurate asthma management, positioning the company for upselling or new integrations.

Growth Potential With revenues between 1 million and 10 million and ongoing product support and training offerings, there is significant potential to expand sales through targeted outreach to clinics and respiratory specialists.

Emerging Opportunities Recent news of leadership changes and strategic partnerships indicate an evolving company open to new collaborations, providing opportunities for business development efforts focused on expanding market reach in respiratory diagnostics.

Similar companies to FeNO by NIOX® USA

FeNO by NIOX® USA Tech Stack

FeNO by NIOX® USA uses 8 technology products and services including Microsoft Advertising, Google Hosted Libraries, jQuery, and more. Explore FeNO by NIOX® USA's tech stack below.

  • Microsoft Advertising
    Advertising
  • Google Hosted Libraries
    Content Delivery Network
  • jQuery
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Floating UI
    Javascript Libraries
  • UPS
    Logistics
  • Algolia
    Search Engines
  • Cloudflare Bot Management
    Security

FeNO by NIOX® USA's Email Address Formats

FeNO by NIOX® USA uses at least 2 format(s):
FeNO by NIOX® USA Email FormatsExamplePercentage
First.Last@circassia.comJohn.Doe@circassia.com
92%
FirstLast@circassia.comJohnDoe@circassia.com
5%
First.Middle@circassia.comJohn.Michael@circassia.com
1%
First-Last@circassia.comJohn-Doe@circassia.com
2%
First.Last@niox.comJohn.Doe@niox.com
72%
FirLast@niox.comJohDoe@niox.com
17%
FiLast@niox.comJoDoe@niox.com
5%
FLast@niox.comJDoe@niox.com
6%

Frequently Asked Questions

Where is FeNO by NIOX® USA's headquarters located?

Minus sign iconPlus sign icon
FeNO by NIOX® USA's main headquarters is located at 1100 Perimeter Park Drive Suite 114 Morrisville, North Carolina 27560 United States. The company has employees across 2 continents, including North AmericaEurope.

What is FeNO by NIOX® USA's official website and social media links?

Minus sign iconPlus sign icon
FeNO by NIOX® USA's official website is niox.com and has social profiles on LinkedIn.

What is FeNO by NIOX® USA's NAICS code?

Minus sign iconPlus sign icon
FeNO by NIOX® USA's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does FeNO by NIOX® USA have currently?

Minus sign iconPlus sign icon
As of June 2026, FeNO by NIOX® USA has approximately 10 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: S. H.Chief Operating Officer: J. E.Chief Commercial Officer: L. S.. Explore FeNO by NIOX® USA's employee directory with LeadIQ.

What industry does FeNO by NIOX® USA belong to?

Minus sign iconPlus sign icon
FeNO by NIOX® USA operates in the Medical Equipment Manufacturing industry.

What technology does FeNO by NIOX® USA use?

Minus sign iconPlus sign icon
FeNO by NIOX® USA's tech stack includes Microsoft AdvertisingGoogle Hosted LibrariesjQueryUnderscore.jsFloating UIUPSAlgoliaCloudflare Bot Management.

What is FeNO by NIOX® USA's email format?

Minus sign iconPlus sign icon
FeNO by NIOX® USA's email format typically follows the pattern of First.Last@circassia.com. Find more FeNO by NIOX® USA email formats with LeadIQ.

When was FeNO by NIOX® USA founded?

Minus sign iconPlus sign icon
FeNO by NIOX® USA was founded in 2006.

FeNO by NIOX® USA

Medical Equipment ManufacturingNorth Carolina, United States2-10 Employees

NIOX Group plc is a company that specializes in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma.

NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use and can be used in a variety of settings, including clinics, hospitals, and primary care settings.

NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX® is also committed to offering additional training and support for healthcare professionals.

Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage asthma.

References:
1. Alving K et al. Validation of a new portable exhaled nitric oxide analyzer, NIOX VERO®: randomized studies in asthma. Pulm Ther. 2017;3:207-218.
2. Gao J et al. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy, Asthma & Clinical Immunology. 2018;1
3. Busse WW et al. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Lancet Respir Med. 2021;9(10):1165-1173.
4. Menzies-Gow A et al. Clinical utility of fractional exhaled nitric oxide in severe asthma management. Eur Respir J. 2020;55(3):1901633.
5. NIOX®. Data on File; MKT-DOF-007.

Section iconCompany Overview

Headquarters
1100 Perimeter Park Drive Suite 114 Morrisville, North Carolina 27560 United States
Website
niox.com
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2006
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    FeNO by NIOX® USA's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    FeNO by NIOX® USA's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.